Portfolio (Quarterly)
Guide ↗
Siren, L.L.C.
· CIK 0002005245| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 81 | MSLE | Satellos Bioscience Inc | Healthcare | 892,074.0 | $6.9M | 0.14% | NEW | — | $7.78 | +26.2% |
| 82 | DT | Dynatrace, Inc | Technology | 155,000.0 | $6.8M | 0.14% | NEW | — | $43.91 | +12.2% |
| 83 | AAPL CALL | Apple Inc | Technology | 23,000.0 | $6.7M | 0.14% | NEW | — | $289.36 | +7.1% |
| 84 | — | Tenax Therapeutics Inc | — | 427,141.0 | $6.2M | 0.13% | NEW | — | $14.55 | — |
| 85 | — | vTv Therapeutics Inc | — | 163,000.0 | $6.1M | 0.12% | NEW | — | $37.65 | — |
| 86 | — | Eloxx Pharmaceuticals Inc | — | 400,000.0 | $5.6M | 0.11% | NEW | — | $13.88 | — |
| 87 | AGMB | Agomab Therapeutics NV | Healthcare | 411,250.0 | $5.3M | 0.11% | NEW | — | $12.98 | +5.8% |
| 88 | BABA | Alibaba Group Holding Ltd | Consumer Cyclical | 50,000.0 | $4.8M | 0.10% | NEW | — | $95.98 | +33.6% |
| 89 | KRRO | Korro Bio Inc | Healthcare | 347,718.0 | $4.6M | 0.09% | NEW | — | $13.18 | +0.3% |
| 90 | CLBT | Cellebrite DI Ltd | Technology | 311,544.0 | $4.5M | 0.09% | NEW | — | $14.60 | -24.7% |
| 91 | IVVD | Invivyd Inc | Healthcare | 5,000,000.0 | $4.4M | 0.09% | NEW | — | $0.87 | -0.5% |
| 92 | — | Ouster Inc | — | 67,500.0 | $4.2M | 0.09% | NEW | — | $62.52 | — |
| 93 | — | Palisade Bio Inc | — | 2,000,000.0 | $4.2M | 0.09% | NEW | — | $2.09 | — |
| 94 | AEVA | Aeva Technologies Inc | Consumer Cyclical | 145,459.0 | $4.2M | 0.09% | NEW | — | $28.72 | -26.8% |
| 95 | SEER | Seer Inc | Healthcare | 2,458,673.0 | $4.1M | 0.08% | NEW | — | $1.66 | +21.7% |
| 96 | NBP | NovaBridge Biosciences | Healthcare | 2,004,739.0 | $3.9M | 0.08% | NEW | — | $1.95 | -3.1% |
| 97 | GTLB | GitLab Inc | Technology | 125,000.0 | $3.8M | 0.08% | NEW | — | $30.53 | +35.9% |
| 98 | — | Odyssey Therapeutics Inc | — | 200,000.0 | $3.7M | 0.08% | NEW | — | $18.71 | — |
| 99 | FHTX | Foghorn Therapeutics Inc | Healthcare | 720,720.0 | $3.5M | 0.07% | NEW | — | $4.88 | +38.3% |
| 100 | AGEN | Agenus Inc | Healthcare | 1,064,250.0 | $3.3M | 0.07% | NEW | — | $3.06 | +146.1% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
92.4%
Technology
3.9%
Communication Services
1.8%
Financial Services
1.3%
Consumer Cyclical
0.6%
Real Estate
0.0%